Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke. Issue 3 (March 2017)
- Record Type:
- Journal Article
- Title:
- Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke. Issue 3 (March 2017)
- Main Title:
- Stroke With Unknown Time of Symptom Onset
- Authors:
- Thomalla, Götz
Boutitie, Florent
Fiebach, Jochen B.
Simonsen, Claus Z.
Nighoghossian, Norbert
Pedraza, Salvador
Lemmens, Robin
Roy, Pascal
Muir, Keith W.
Ebinger, Martin
Ford, Ian
Cheng, Bastian
Galinovic, Ivana
Cho, Tae-Hee
Puig, Josep
Thijs, Vincent
Endres, Matthias
Fiehler, Jens
Gerloff, Christian - Abstract:
- Abstract : Background and Purpose—: We describe clinical and magnetic resonance imaging (MRI) characteristics of stroke patients with unknown time of symptom onset potentially eligible for thrombolysis from a large prospective cohort. Methods—: We analyzed baseline data from WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial), an investigator-initiated, randomized, placebo-controlled trial of MRI-based thrombolysis in stroke patients with unknown time of symptom onset. MRI judgment included assessment of the mismatch between visibility of the acute ischemic lesion on diffusion-weighted imaging and fluid-attenuated inversion recovery. Results—: Of 1005 patients included, diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch was present in 479 patients (48.0%). Patients with daytime-unwitnessed stroke (n=138, 13.7%) had a shorter delay between symptom recognition and hospital arrival (1.5 versus 1.8 hours; P =0.002), a higher National Institutes of Stroke Scale score on admission (8 versus 6; P <0.001), and more often aphasia (72.5% versus 34.0%; P <0.001) when compared with stroke patients waking up from nighttime sleep. Frequency of diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch was comparable between both groups (43.7% versus 48.7%; P =0.30). Conclusions—: Almost half of the patients with unknown time of symptom onset stroke otherwise eligible forAbstract : Background and Purpose—: We describe clinical and magnetic resonance imaging (MRI) characteristics of stroke patients with unknown time of symptom onset potentially eligible for thrombolysis from a large prospective cohort. Methods—: We analyzed baseline data from WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial), an investigator-initiated, randomized, placebo-controlled trial of MRI-based thrombolysis in stroke patients with unknown time of symptom onset. MRI judgment included assessment of the mismatch between visibility of the acute ischemic lesion on diffusion-weighted imaging and fluid-attenuated inversion recovery. Results—: Of 1005 patients included, diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch was present in 479 patients (48.0%). Patients with daytime-unwitnessed stroke (n=138, 13.7%) had a shorter delay between symptom recognition and hospital arrival (1.5 versus 1.8 hours; P =0.002), a higher National Institutes of Stroke Scale score on admission (8 versus 6; P <0.001), and more often aphasia (72.5% versus 34.0%; P <0.001) when compared with stroke patients waking up from nighttime sleep. Frequency of diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch was comparable between both groups (43.7% versus 48.7%; P =0.30). Conclusions—: Almost half of the patients with unknown time of symptom onset stroke otherwise eligible for thrombolysis had MRI findings making them likely to be within a time window for safe and effective thrombolysis. Patients with daytime onset unwitnessed stroke differ from wake-up stroke patients with regards to clinical characteristics but are comparable in terms of MRI characteristics of lesion age. Clinical Trial Registration—: URL:http://www.clinicaltrials.gov . Unique identifier: NCT01525290. URL:https://www.clinicaltrialsregister.eu . Unique identifier: 2011-005906-32. … (more)
- Is Part Of:
- Stroke. Volume 48:Issue 3(2017)
- Journal:
- Stroke
- Issue:
- Volume 48:Issue 3(2017)
- Issue Display:
- Volume 48, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 48
- Issue:
- 3
- Issue Sort Value:
- 2017-0048-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-03
- Subjects:
- aphasia -- informed consent -- magnetic resonance imaging -- risk factors -- stroke
Cerebrovascular disease -- Periodicals
Cerebral circulation -- Periodicals
616.81 - Journal URLs:
- http://ovidsp.tx.ovid.com/sp-3.16.0b/ovidweb.cgi?&S=GJCMFPNHCPDDNANKNCKKCFFBNGMHAA00&Browse=Toc+Children%7cYES%7cS.sh.15204_1441956414_76.15204_1441956414_88.15204_1441956414_96%7c411%7c50 ↗
http://www.stroke.ahajournals.org/ ↗
http://stroke.ahajournals.org/ ↗
http://journals.lww.com ↗
http://www.lww.com/Product/0039-2499 ↗ - DOI:
- 10.1161/STROKEAHA.116.015233 ↗
- Languages:
- English
- ISSNs:
- 0039-2499
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8474.900000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4528.xml